Soleus Private Equity Fund I, L.p. - Net Worth and Insider Trading
Soleus Private Equity Fund I, L.p. Net Worth
The estimated net worth of Soleus Private Equity Fund I, L.p. is at least $348,272 dollars as of 2024-05-23. Soleus Private Equity Fund I, L.p. is the 10% Owner of Lyra Therapeutics Inc and owns about 1,055,369 shares of Lyra Therapeutics Inc (LYRA) stock worth over $348,272. Details can be seen in Soleus Private Equity Fund I, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Soleus Private Equity Fund I, L.p. has not made any transactions after 2020-05-05 and currently still holds the listed stock(s).
Transaction Summary of Soleus Private Equity Fund I, L.p.
Soleus Private Equity Fund I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Soleus Private Equity Fund I, L.p. owns 2 companies in total, including Lyra Therapeutics Inc (LYRA) , and BioAtla Inc (BCAB) .
Insider Ownership Summary of Soleus Private Equity Fund I, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LYRA | Lyra Therapeutics Inc | 2020-05-05 | 10 percent owner |
| BCAB | BioAtla Inc | 2020-12-15 | 10 percent owner |
Soleus Private Equity Fund I, L.p. Latest Holdings Summary
Soleus Private Equity Fund I, L.p. currently owns a total of 1 stock. Soleus Private Equity Fund I, L.p. owns 1,055,369 shares of Lyra Therapeutics Inc (LYRA) as of May 5, 2020, with a value of $348,272.
Latest Holdings of Soleus Private Equity Fund I, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics Inc | 2020-05-05 | 1,055,369 | 0.33 | 348,272 |
Holding Weightings of Soleus Private Equity Fund I, L.p.
Soleus Private Equity Fund I, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Soleus Private Equity Fund I, L.p. has made a total of 2 transactions in Lyra Therapeutics Inc (LYRA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Lyra Therapeutics Inc is the sale of 16,909 shares on May 5, 2020, which brought Soleus Private Equity Fund I, L.p. around $270,544.
Insider Trading History of Soleus Private Equity Fund I, L.p.
- 1
Soleus Private Equity Fund I, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Soleus Private Equity Fund I, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Soleus Private Equity Fund I, L.p. is -16.16%. GuruFocus also compares Soleus Private Equity Fund I, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Soleus Private Equity Fund I, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Soleus Private Equity Fund I, L.p.'s insider trading performs compared to the benchmark.
Performance of Soleus Private Equity Fund I, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.2 | | | | | |
| Relative Return to S&P 500(%) | -15.55 | | | | | |
Soleus Private Equity Fund I, L.p. Ownership Network
Soleus Private Equity Fund I, L.p. Owned Company Details
What does Lyra Therapeutics Inc do?
Who are the key executives at Lyra Therapeutics Inc?
Soleus Private Equity Fund I, L.p. is the 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Lyra Therapeutics Inc (LYRA) Insider Trades Summary
Over the past 18 months, Soleus Private Equity Fund I, L.p. made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.
Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lyra Therapeutics Inc Insider Transactions
Soleus Private Equity Fund I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Soleus Private Equity Fund I, L.p.. You might contact Soleus Private Equity Fund I, L.p. via mailing address: C/o Soleus Private Equity Gp I, Llc, 104 Field Point Road, 2nd Floor, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
